The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Salussolia, Hana
    Director born in April 1974
    Individual (2 offsprings)
    Officer
    2014-06-23 ~ now
    OF - Director → CIF 0
    Ms Hana Salussolia
    Born in April 1974
    Individual (2 offsprings)
    Person with significant control
    2017-06-19 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Seifalian, Alexander Marcus
    Prof Of Nano & Regmedicine & Resear born in March 1956
    Individual (4 offsprings)
    Officer
    2014-06-23 ~ now
    OF - Director → CIF 0
    Mr Alexander Marcus Seifalian
    Born in March 1956
    Individual (4 offsprings)
    Person with significant control
    2017-06-19 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

NANOREGMED LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Turnover/Revenue
35,179 GBP2022-07-01 ~ 2023-06-30
50,463 GBP2021-07-01 ~ 2022-06-30
Raw materials and consumables used in the production process
-595 GBP2022-07-01 ~ 2023-06-30
-21,391 GBP2021-07-01 ~ 2022-06-30
Staff Costs/Employee Benefits Expense
-4,310 GBP2022-07-01 ~ 2023-06-30
-4,310 GBP2021-07-01 ~ 2022-06-30
Expenses related to depreciation, amortization, and impairment of assets
-651 GBP2022-07-01 ~ 2023-06-30
-1,237 GBP2021-07-01 ~ 2022-06-30
Tax/Tax Credit on Profit or Loss on Ordinary Activities
0 GBP2022-07-01 ~ 2023-06-30
-374 GBP2021-07-01 ~ 2022-06-30
Profit/Loss
-14,408 GBP2022-07-01 ~ 2023-06-30
22,951 GBP2021-07-01 ~ 2022-06-30
Fixed Assets
1,960 GBP2023-06-30
1,663 GBP2022-06-30
Current Assets
46,914 GBP2023-06-30
60,280 GBP2022-06-30
Creditors
Amounts falling due within one year
-4,940 GBP2022-06-30
Net Current Assets/Liabilities
46,914 GBP2023-06-30
55,340 GBP2022-06-30
Total Assets Less Current Liabilities
48,874 GBP2023-06-30
57,003 GBP2022-06-30
Net Assets/Liabilities
48,695 GBP2023-06-30
57,003 GBP2022-06-30
Equity
48,695 GBP2023-06-30
57,003 GBP2022-06-30
Average Number of Employees
12022-07-01 ~ 2023-06-30

Related profiles found in government register
  • NANOREGMED LTD
    Info
    Registered number 09096454
    London Bioscience Innovation Centre, 2 Royal College Street, London NW1 0NH
    Private Limited Company incorporated on 2014-06-23 (11 years). The company status is Active.
    The last date of confirmation statement was made at 2024-10-27
    CIF 0
  • NANOREGMED LTD
    S
    Registered number 09096454
    The London Bioscience Innovation Centre, 2 Royal College Street, London, England, NW1 0NH
    Limited Company in England And Wales, United Kingdom
    CIF 1
  • NANOREGMED
    S
    Registered number 09096454
    London Bioscience Innovation Centre, 2 Royal College Street, London, United Kingdom, NW1 0NH
    Ltd in Companies House, United Kingdom
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    55-56 Russell Square, London, England
    Active Corporate (5 parents)
    Net Assets/Liabilities (Company account)
    -711 GBP2023-11-30
    Person with significant control
    2021-11-08 ~ now
    CIF 2 - Ownership of shares – More than 25% but not more than 50%OE
    CIF 2 - Ownership of voting rights - More than 25% but not more than 50%OE
  • 2
    The London Bioscience Innovation Centre C/o Nanoregmed Ltd, 2 Royal College Street, London
    Active Corporate (4 parents)
    Equity (Company account)
    240,882 GBP2023-11-30
    Person with significant control
    2020-12-09 ~ now
    CIF 1 - Ownership of shares – More than 25% but not more than 50%OE
    CIF 1 - Ownership of voting rights - More than 25% but not more than 50%OE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.